# H&Q Asia Pacific H&Q Asia Pacific is a Private Equity based in Central, Hong Kong. ## Overview - **Organization type:** Private Equity - **Headquarters:** Central, Hong Kong - **Region:** Asia - **Address:** 1650B, 16th Floor The Hong Kong Club Building, 3A Chater Road, Central, Hong Kong - **Founded:** 1985 - **Assets under management:** 3.4B (Altss estimate) - **Website:** www.hqap.com - **LinkedIn:** https://www.linkedin.com/company/everbright-financial-holding-h-q-asia-pacific ## About Ta-lin Hsu founded H&Q Asia Pacific in 1985 after his tenure as a managing director at Hambrecht & Quist, creating one of the earliest private equity vehicles dedicated entirely to the Asia-Pacific region. The firm established its independence early, operating as a standalone entity that carried forward the H&Q brand while developing a deeply localized investment culture across Greater China, Korea, Japan, and Southeast Asia. H&QAP pursues a dual-track strategy, combining later-stage control buyouts with venture capital investments in technology, healthcare services, and financial services. The firm has backed companies through critical expansion phases, including LoveSac, a consumer brand it invested in during the 2010s, and semiconductor manufacturing businesses in Korea and Taiwan. Its geographic footprint spans Hong Kong, where the firm is headquartered, alongside offices in Silicon Valley, Seoul, Tokyo, Manila, Singapore, and Shanghai — enabling cross-border deal sourcing that few Asian GPs replicate effectively. Over nearly four decades, H&QAP has raised eight flagship funds, deploying capital into mid-market companies that require both operational restructuring and growth capital. The firm's team includes senior managing directors who have navigated multiple regional cycles: Dennis Yoon and Meng Han Lim run investments from Hong Kong, while Hiroshi Ota leads the Japan office. In 2021, the firm closed H&QAP Asia-Pacific Growth Fund VIII at approximately $500 million, targeting healthcare and technology services across Korea and Greater China. H&QAP's structural differentiator lies in its dual-registration model: the firm maintains a full-time presence in Silicon Valley, allowing portfolio companies to access US technology partnerships and, in some cases, pursue dual-listing strategies. This bicoastal architecture — Asia for deal flow and operations, Silicon Valley for strategic value — sets it apart from purely region-locked pan-Asian funds. ## Sectors - Enterprise Software - FinTech - Healthcare Services - Industrial Tech - Consumer ## People - Ta-lin Hsu — Chairman and Founder - Dennis Yoon — Managing Director - Meng Han Lim — Managing Director - Hiroshi Ota — Managing Director, Japan ## Questions ### How does H&QAP split its investment focus between buyouts and venture capital? H&Q Asia Pacific runs a blended strategy. In Korea, Japan, and mature markets, the firm primarily pursues later-stage control buyouts and growth equity investments in industrial and services companies. In Greater China and Southeast Asia, the portfolio tilts toward earlier-stage venture and growth investments in technology, enterprise software, and healthcare services. This staging flex reflects the maturity curve of each sub-region's private capital markets rather than a rigid mandate. ### Who leads investment decisions at H&QAP, and how are country teams structured? Chairman Ta-lin Hsu retains ultimate investment committee authority, with managing directors like Dennis Yoon and Meng Han Lim running day-to-day deal execution from Hong Kong. The country offices in Seoul, Tokyo, and Shanghai operate with significant sourcing autonomy, while the Silicon Valley office does not originate local deals — it supports portfolio companies with strategic partnerships and eventual exit preparation. ### What is the firm's relationship with the original Hambrecht & Quist, and does H&QAP share economics with its namesake? H&Q Asia Pacific has been an independent organization since its founding in 1985. While it originated as an Asia-focused affiliate of the San Francisco-based investment bank Hambrecht & Quist, the two entities separated decades ago. H&QAP has no current economic or operational ties to the bank — which was acquired by Chase Manhattan in 1999 — and retains the brand only through historical association. ### Which sectors does H&QAP actively avoid? The firm has historically avoided raw-materials extraction, mining, and infrastructure projects that require multi-decade capital commitments and are subject to commodity-cycle risk. It also maintains a conservative posture on biotech platforms that lack existing revenue. H&QAP's healthcare investments concentrate on services and medical-device distribution rather than drug discovery. ### What is H&QAP's known posture on China exposure in its current fund? H&QAP Asia-Pacific Growth Fund VIII, which closed in 2021, identified Korea and Greater China as primary deployment targets, with a particular emphasis on healthcare services and technology. The firm maintains on-the-ground investment teams in Shanghai and Hong Kong. It has historically managed China exposure by investing through offshore holding structures, which provides liquidity flexibility compared to onshore RMB funds. ## Related profiles - [Glouston Capital Partners](https://altss.com/profile/glouston-capital-partners) - [Loyal Valley Capital](https://altss.com/profile/loyal-valley-capital) --- Last updated: 2026-07-06T00:34:10.355Z Canonical page: https://altss.com/profile/h-q-asia-pacific Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology